Global Hematology Diagnostics Market Nears the $8 Billion Mark by 2027 - Comprehensive Industry Insights & OpportunitiesHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Hematology Diagnostics Market Nears the $8 Billion Mark by 2027 - Comprehensive Industry Insights & OpportunitiesGlobeNewswireJanuary 7, 2020ReblogShareTweetShareDublin, Jan. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Hematology Diagnostics Market Outlook and Projections, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
The global hematology diagnostics market reached USD 4,702.88 million in 2018 and is expected to reach USD 7,989.73 million by 2027, by registering a CAGR of 6.06%, across the globe. This is primarily attributed to the growing demand for advanced diagnostics across the world.North America had a market share of 37.94% in the year 2018 and is expected to dominate the market, over the forecast period. The growth in the region can be attributed to increase in investments towards healthcare from government and private entities to maintain the highest quality of care offered in healthcare facilities.The US is the major country driving the growth in the region, reaching a market value of USD 1,567.36 million in 2018 and is expected to grow at a CAGR of 6.23% over the forecast period i.e. 2020-2027. On the back of rising adoption of innovative diagnostic methods focused on minimally in-vitro diagnostics, the market is expected to grow over the forecast period.The Asia Pacific region captured a market size of USD 1,002.46 million in the year 2018 and is expected to reach USD 1,820.23 million by 2027, with a CAGR of 6.85%. The market is primarily led by the demand from China, with a market of USD 367.57 million in the year 2018, and it is expected to grow at a CAGR of 7.75%.With the rising availability of advanced healthcare in this region along with rising number of manufacturers investing in countries such as China, Japan, & India to address the growing demand for advanced diagnostics in this region, the demand for hematology diagnostics products in this region is expected to witness a rapid growth over the forecast period.Europe is expected to reach a market size of USD 2,114.07 million by 2027. It has been observed that with the availability of innovative treatment modalities, there has been a rise in demand for effective diagnostic products in the region for time sensitive diagnosis. Primarily driven by the demand from Germany, UK, France & Italy, this region is expected to showcase a high demand over the forecast period.In comparison, the Latin America and Middle East & Africa region is presently generating a moderate demand for the hematology diagnostics products. It has been observed that there are a high number of patients, who opt for various medical procedures, travelling to other geographies with adequate healthcare resources. While this boosts the medical tourism in the travelled country, it points out the wide gap in the availability of health resources in these regions.However, with gradually rising disposable income, encouraging government regulatory policies, and a potential interest of global manufacturers to have a direct market presence in this region, it is expected that the market for hematology diagnostics in these regions would grow over the forecast period.
Key Topics Covered
1 Introduction1.1. Market Definition1.2. Market Segmentation1.3. Product Overview2 Assumptions and Acronyms3 Research Methodology3.1. Variables (Dependent and Independent)3.2. Multi Factor Based Sensitivity Model4 Executive Summary - Global Hematology Diagnostics Market5 Key Market Opportunities6 Regulatory Landscape7 List of Devices7.1. Hematology Diagnostics7.2. Companion Diagnostics8 Overview of Applications of Companion Diagnostics in Pharmacodynamics/Pharmacokinetics9 Analysis of Market Dynamics9.1. Drivers9.2. Restraints9.3. Trends10 Market Risk Analysis10.1. Demand Risk Analysis10.2. Supply Risk Analysis11 Global Hematology Diagnostics Market Outlook11.1. Market Size and Forecast, 2018-202711.1.1. By Value (Usd Million)11.2. Global Hematology Diagnostics Market Segmentation, 2018-202711.2.1. By ProductReagents, Instruments & Analyzers and Software & Services, 2018-2027F (Usd Million)11.2.2. By PortabilityPoint-Of-Care (Poc) Devices and Standalone, 2018-2027F (Usd Million)11.2.3. By ApplicationsOncology, Malaria, Anemia, Bood Count, Platelet Function, and Others (Hiv, Diabetes, Rare Genetic Disorders), 2018-2027F (Usd Million)Anemia: Sickle Cell Anemia, Thalassemia and Others (Vitamin Deficiency Anemia, Iron Deficiency Anemia), 2018-2027F (Usd Million)11.2.4. By End-userHospitals, Diagnostic Labs, Ambulatory Surgical Centers, Clinics and Others (Research & Educational Institutes), 2018-2027F (Usd Million)12 North America Hematology Diagnostics Market Outlook13 Europe Hematology Diagnostics Market Outlook14 Asia-Pacific Hematology Diagnostics Market Outlook15 Latin America Hematology Diagnostics Market Outlook16 Middle East & Africa Hematology Diagnostics Market Outlook17 Competitive Structure17.1. Detailed Overview17.2. Assessment of Key Product Offerings17.3. Analysis of Growth Strategies17.4. Exhaustive Analysis on Key Finacial Indicators17.5. Regional Presence17.6. Key Partners and Collaborations17.7. Recent News and Developments17.8. Company ProfilesAbbottSysmexBeckman Coulter Inc.Siemens Healthcare GmbHBoule Diagnostics AbF. Hoffmann-La Roche Ltd.Shenzhen Mindray Bio-Medical Electronics Co. Ltd.Bio-Rad Laboratories Inc.CellavisionOther Prominent Players18 Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/gtjfpjStory continuesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextSiteOne Landscape Supply adds Lowe's veteran to its C-SuiteAmerican City Business JournalsIs WisdomTree Japan SmallCap Dividend ETF (DFJ) a Strong ETF Right Now?ZacksChina's blood donations dry up as coronavirus outbreak quells givingReutersBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoTennessee professor charged with hiding China ties from NASAQuartzMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoSouth Koreans are visiting the US instead of JapanQuartzDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatch